Alethia Biotherapeutics

Alethia Biotherapeutics is developing monocolonal antibody therapeutics.

History:

Formed in 2002 as a spinout of the Functional Genomic unit of SignalGene.

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
North America

Research Focus:
Genomics Disease Therapeutics-Research

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: